Heberprot-P, a unique drug developed in Cuba for patients with diabetic foot ulcers

Sancti Spiritus Outstanding in Heberprot-P Treatment Actions

Heberprot-P is a unique drug developed in Cuba.

By Arelys García Acosta | Escambray

Over 70 per cent of diabetic foot ulcer cases in Sancti Spiritus are handled at primary-health-care institutions, where Heberprot-P treatment is possible.

The abovementioned statement was made known during a meeting held this Friday in this city, where experts from all over the island discussed how to systematize early actions involving diabetic patients.

Rafael Ibargollin Ulloa, coordinator of the National Program for the Extension of Heberprot-P in central Cuba, emphasized the convenience of treating ulcerations in early stages; this way patients heal sooner, and subsequent complications can be prevented.

Over 300 diabetic patients have been so far diagnosed in Sancti Spiritus this year. This territory outstands in the Heberprot-B-related program implementation, and is only preceded by Isla de la Juventud.

Some 20 626 diabetic foot ulcer patients have been treated in hospitals, polyclinics, and diabetic people assistance centers, since  the drug was first used at primary health care level in the island.

(Translated by Escambray)

Advertisements

Leave a comment

No comments yet.

Comments RSS

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s